AMH Test in Australia

What an AMH test is

Anti-Müllerian hormone is produced by the granulosa cells of small pre-antral and early antral follicles, so its concentration in blood tracks how many of those small follicles remain.

Every ovary begins with a finite pool of follicles that declines steadily with age. Because AMH is secreted by the earliest recruitable follicles rather than by the single follicle that a given cycle happens to select, its level stays comparatively stable across the menstrual cycle. That stability is exactly why it displaced day-3 FSH as the preferred first-line ovarian reserve marker in most Australian fertility practice — a sample can be taken on any day.

Australian pathology laboratories report AMH in picomoles per litre. Much of the international literature, and most United States sources, report nanograms per millilitre. The conversion is straightforward: ng/mL multiplied by 7.14 gives pmol/L. A woman told her AMH is '2.0' in an American forum and '14' by an Australian lab may be describing the same result.

It is important to be precise about what the number represents. AMH is a quantity signal. It says something about how many follicles remain; it says nothing about the chromosomal quality of the eggs within them, which is driven by age rather than by AMH.

Why AMH is measured

AMH is measured to estimate ovarian reserve before fertility treatment or egg freezing, to help predict response to ovarian stimulation, and as a supporting marker in the assessment of polycystic ovary syndrome.

In assisted reproduction, AMH is used chiefly to anticipate how the ovaries will respond to stimulation. A very low level suggests a poor response and fewer eggs collected; a very high level flags a risk of over-response and ovarian hyperstimulation syndrome, which changes how a specialist plans the cycle. This predictive use is well supported and is the test's strongest application.

Outside a fertility clinic, AMH is often requested by women who want information about their reproductive timeline. It can be genuinely useful context — particularly for those considering egg freezing or planning to delay pregnancy — but it is not a pregnancy predictor. Population studies have repeatedly found that among women without known infertility, AMH does not reliably predict the chance of conceiving naturally within a given timeframe.

AMH is also elevated in polycystic ovary syndrome because the characteristic feature of PCOS is a large number of small antral follicles. International PCOS guidance, led from Australia by the Monash Centre for Health Research and Implementation, has recognised AMH as a supporting marker in adults, used alongside clinical and biochemical assessment rather than as a standalone diagnostic.

What high AMH results can indicate

A high AMH usually reflects a large pool of small antral follicles, most commonly in polycystic ovary syndrome, and indicates a higher likelihood of strong ovarian response to stimulation.

In practical terms a high AMH is not, in itself, a problem — a larger follicle pool is generally an advantage in fertility treatment. What it changes is the way a specialist manages stimulation, because the same drug dose that produces a normal response in an average responder can produce an excessive one here, with a corresponding risk of ovarian hyperstimulation syndrome.

Because raised AMH is common in PCOS, an unexpectedly high result in someone with irregular cycles, acne or unwanted hair growth is a reasonable prompt to discuss a broader assessment with a GP — cycle history, androgens, glucose and insulin, and pelvic ultrasound where indicated. AMH alone does not diagnose PCOS.

Rarely, markedly elevated AMH is associated with granulosa cell tumours, which is one reason an unexpected extreme result should always be reviewed by a doctor rather than interpreted at home.

What low AMH results can indicate

A low AMH indicates a smaller remaining follicle pool for a woman's age, and predicts fewer eggs retrieved in a stimulated cycle — but it does not mean pregnancy is impossible.

AMH falls naturally with age, so 'low' has to be read against age. A level that would be unremarkable at 42 is a meaningful finding at 28, where it may warrant assessment for premature ovarian insufficiency along with FSH, oestradiol and, in some cases, genetic testing.

Low AMH can also follow ovarian surgery, chemotherapy or radiotherapy, and is seen in some autoimmune conditions. Hormonal contraception, particularly long-term combined pills, can suppress measured AMH modestly — typically by around 20% — which is worth mentioning to whoever interprets the result.

The most important framing point: a single low AMH result is not a verdict on your ability to conceive. Many women with low AMH conceive naturally. What a low result reliably signals is that if fertility treatment is being planned, time and specialist advice matter more, and a referral to a fertility specialist through your GP is the appropriate next step.

AMH reference ranges by age (Australian units)

Australian laboratories report AMH in pmol/L against age-banded reference intervals, because a level that is normal at 40 would be low at 25.

Different immunoassay platforms have historically produced different AMH values from the same sample, so results are best compared over time on the same assay at the same laboratory.

Who should consider an AMH test

AMH testing is most informative for women planning fertility treatment or egg freezing, women with irregular cycles, and women who want an objective baseline before delaying pregnancy.

AMH is not recommended as a general population screening test in women who are not seeking fertility information, because a result in isolation frequently causes more anxiety than it resolves.

• Considering egg freezing, IVF or another assisted reproductive treatment.
• Trying to conceive without success, particularly after age 35.
• Irregular or absent periods, or a suspected diagnosis of PCOS.
• Previous ovarian surgery, chemotherapy or pelvic radiotherapy.
• A family history of early menopause or premature ovarian insufficiency.
• Wanting a documented baseline before deferring pregnancy for several years.

How AMH testing works with FORM in Australia

You order directly, we issue an accredited-lab pathology request, and you receive a written interpretation to take to your GP or fertility specialist.

FORM provides testing and interpretation. We do not provide fertility treatment, prescribe medicines, or replace specialist care.

• Order online without a GP referral.
• Receive your pathology request form by email as a PDF.
• Attend a NATA-accredited (ISO 15189) collection centre on any day of your cycle.
• Receive a written, plain-English report explaining your result in context of your age.
• Discuss the result with your GP or a registered fertility specialist.